Developer docs
API playgroundTry for free, no card

Search company profiles

Entegrion

Full company profile

uuid0002rwy

Namestring
Entegrion
Legal namestring
Entegrion, Inc.
Websiteurl
entegrion.com
Company typeenum
Private
Founded yearint
2002
Short descriptiontext

Entegrion is a Durham, NC-based life sciences company that develops and sells the VCM viscoelastic coagulation monitoring platform for point-of-care blood coagulation assessment, serving hospitals, emergency medicine providers, and veterinary practices in Europe and CE-accepting regions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
viscoelastic coagulation monitoring, point of care diagnostics, hemostasis assessment, blood coagulation testing, veterinary coagulation monitoring
Industry2 codes
PRIMARYHLAHAOAC
Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAFAMAC
Hematology & Coagulation Laboratories
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Point-of-Care Coagulation Diagnostics
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1VCM Hardware and Consumables Sales
TypeHardware Sales
Description

Sale of VCM viscoelastic coagulation monitoring instruments and associated testing cartridges to healthcare facilities. The company sells both veterinary (VCMVet) and human-use (VCM Cascade) products through direct sales and e-commerce channels for existing customers.

entegrion.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1VCM™
Description

Viscoelastic coagulation monitor for human use - a point of care system for blood coagulation monitoring

entegrion.com
+2 more records
Core offering1 text field

Entegrion develops and manufactures the VCM (Viscoelastic Coagulation Monitor), a point-of-care system that provides rapid, real-time hemostasis assessment using a small amount of fresh whole blood without chemical accelerants or sample manipulation. The platform is commercialized in two variants: VCMVet for veterinary practices and VCM Cascade for human clinical use in Europe and CE Mark-accepting regions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 800 million PT/PTT coagulation tests requested worldwide in point of care testing annually, indicating significant market opportunity
Product overview1 text field

Entegrion offers the VCM (Viscoelastic Coagulation Monitor) platform, a point of care system for blood coagulation monitoring. The core VCM technology has been developed into two distinct sub-brands: VCMVet for veterinary care applications and VCM Cascade for human clinical use. Both products provide rapid, real-time hemostasis assessment using fresh whole blood at the bedside with full automation and no chemical modifications required.

Product and service3 records
1VCM (Viscoelastic Coagulation Monitor)
CategoryCoagulation Diagnostic Devices
Description

Point of care system for blood coagulation monitoring that provides rapid, real-time hemostasis assessment using fresh whole blood at the bedside. The fully automated test uses no chemical accelerants and requires no sample manipulation. Targeted at hospitals, emergency departments, surgical centers, and military field environments.

2VCMVet
CategoryVeterinary Diagnostic Devices
Description

Veterinary-specific version of the VCM platform providing rapid, real-time hemostasis assessment at patient side for animals. Designed as a true point of care solution with three-step operation using untreated whole blood samples.

3VCM Cascade
CategoryCoagulation Diagnostic Devices
Description

Human clinical version of the VCM analyzer providing point of care coagulation monitoring for human patients. Uses 300 microliters of whole blood directly from syringe with three-step operation and results displayed on touch screen within minutes.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Werfen markets the ROTEM and Quantra viscoelastic testing systems, the other principal viscoelastic platform competing against TEG and directly comparable to Entegrion's VCM in trauma, surgery, and point-of-care coagulation assessment.

TypeEmerging player
Description

ELITech Group manufactures and distributes specialty coagulation and hemostasis reagents and instruments for clinical laboratories. Comparable to Entegrion in clinical coagulation focus but smaller and emerging relative to the major incumbents.

TypeBroad incumbent
Description

Siemens Healthineers offers central laboratory and POC coagulation analyzers across hospital networks globally, with a broad diagnostics portfolio that competes with Entegrion in hemostasis testing workflows.

TypeOthers
Description

Zoetis is a global animal health company with diagnostics and reference laboratory offerings serving veterinary practices. Comparable to Entegrion's veterinary focus but positioned as an adjacent ecosystem participant rather than a direct viscoelastic competitor.

TypeDirect peer
Description

Stago is a specialized coagulation diagnostics company offering both laboratory and point-of-care hemostasis testing solutions. Directly comparable to Entegrion's clinical coagulation monitoring focus with broader product depth.

TypeBroad incumbent
Description

Hologic acquired HemoSonics and its Quantra QPlus viscoelastic testing system in 2021, making it a broad-incumbent competitor with a more recently developed viscoelastic platform aimed at surgical and perioperative settings.

7Haemonetics Corporation
TypeDirect peer
Description

Haemonetics owns the TEG (thromboelastography) platform, the long-standing market leader in viscoelastic hemostasis testing for trauma, cardiac surgery, and obstetrics. Direct head-to-head competitor to Entegrion's VCM with similar clinical use cases and customer base.

8Abbott
TypeBroad incumbent
Description

Abbott operates a broad diagnostics portfolio including point-of-care coagulation cartridges (i-STAT) widely used in hospitals worldwide. Represents a broad-incumbent competitor whose coagulation offering overlaps with VCM's clinical use cases.

TypeBroad incumbent
Description

IDEXX is the dominant veterinary diagnostics company, with in-clinic chemistry, hematology, and coagulation offerings sold to the same veterinary practices Entegrion targets with VCMVet. Represents a broad-incumbent competitor in the veterinary channel.

TypeBroad incumbent
Description

Roche Diagnostics supplies coagulation testing solutions as part of its broad in-vitro diagnostics franchise and is the dominant central laboratory hemostasis partner for many US and EU hospitals.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Entegrion

Point-of-Care Coagulation Diagnosticsentegrion.com

Entegrion is a Durham, NC-based life sciences company that develops and sells the VCM viscoelastic coagulation monitoring platform for point-of-care blood coagulation assessment, serving hospitals, emergency medicine providers, and veterinary practices in Europe and CE-accepting regions.

Entegrion firmographics

Firmographics
Name
Entegrion
Legal name
Entegrion, Inc.
Website
https://entegrion.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
Entegrion is a Durham, NC-based life sciences company that develops and sells the VCM viscoelastic coagulation monitoring platform for point-of-care blood coagulation assessment, serving hospitals, emergency medicine providers, and veterinary practices in Europe and CE-accepting regions.
Ownership category
akta.pro rank

Entegrion industry classification

Industry
Product category
Point-of-Care Coagulation Diagnostics
NAICS
Medical Laboratories (621511)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHAOAC
Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLAFAMAC
Hematology & Coagulation Laboratories

Keywords

  • Viscoelastic coagulation monitoring
  • Point of care diagnostics
  • Hemostasis assessment
  • Blood coagulation testing
  • Veterinary coagulation monitoring

Where Entegrion is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Entegrion business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. VCM Hardware and Consumables Sales: Sale of VCM viscoelastic coagulation monitoring instruments and associated testing cartridges to healthcare facilities. The company sells both veterinary (VCMVet) and human-use (VCM Cascade) products through direct sales and e-commerce channels for existing customers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Entegrion product offering

Product offering

Core offering

Entegrion develops and manufactures the VCM (Viscoelastic Coagulation Monitor), a point-of-care system that provides rapid, real-time hemostasis assessment using a small amount of fresh whole blood without chemical accelerants or sample manipulation. The platform is commercialized in two variants: VCMVet for veterinary practices and VCM Cascade for human clinical use in Europe and CE Mark-accepting regions.

Product overview

Entegrion offers the VCM (Viscoelastic Coagulation Monitor) platform, a point of care system for blood coagulation monitoring. The core VCM technology has been developed into two distinct sub-brands: VCMVet for veterinary care applications and VCM Cascade for human clinical use. Both products provide rapid, real-time hemostasis assessment using fresh whole blood at the bedside with full automation and no chemical modifications required.

Differentiator

Problem solved

Functional benefit

Brands

  • VCM™: Viscoelastic coagulation monitor for human use - a point of care system for blood coagulation monitoring
  • VCMVet™
  • VCM Cascade™

Products and services

  • VCM (Viscoelastic Coagulation Monitor) Point of care system for blood coagulation monitoring that provides rapid, real-time hemostasis assessment using fresh whole blood at the bedside. The fully automated test uses no chemical accelerants and requires no sample manipulation. Targeted at hospitals, emergency departments, surgical centers, and military field environments.
  • VCMVet Veterinary-specific version of the VCM platform providing rapid, real-time hemostasis assessment at patient side for animals. Designed as a true point of care solution with three-step operation using untreated whole blood samples.
  • VCM Cascade Human clinical version of the VCM analyzer providing point of care coagulation monitoring for human patients. Uses 300 microliters of whole blood directly from syringe with three-step operation and results displayed on touch screen within minutes.

Quantifiable outcome

  • 800 million PT/PTT coagulation tests requested worldwide in point of care testing annually, indicating significant market opportunity

Companies that use Entegrion

Customer profile

Segments3 records

Ideal customer profiles3 records

Entegrion technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Entegrion partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Entegrion competitors and assessment

Company assessment

Direct peers

  • Werfen: Werfen markets the ROTEM and Quantra viscoelastic testing systems, the other principal viscoelastic platform competing against TEG and directly comparable to Entegrion's VCM in trauma, surgery, and point-of-care coagulation assessment.
  • Diagnostica Stago: Stago is a specialized coagulation diagnostics company offering both laboratory and point-of-care hemostasis testing solutions. Directly comparable to Entegrion's clinical coagulation monitoring focus with broader product depth.
  • Haemonetics Corporation: Haemonetics owns the TEG (thromboelastography) platform, the long-standing market leader in viscoelastic hemostasis testing for trauma, cardiac surgery, and obstetrics. Direct head-to-head competitor to Entegrion's VCM with similar clinical use cases and customer base.

Emerging players

  • ELITech Group: ELITech Group manufactures and distributes specialty coagulation and hemostasis reagents and instruments for clinical laboratories. Comparable to Entegrion in clinical coagulation focus but smaller and emerging relative to the major incumbents.

Broad incumbents

  • Siemens Healthineers: Siemens Healthineers offers central laboratory and POC coagulation analyzers across hospital networks globally, with a broad diagnostics portfolio that competes with Entegrion in hemostasis testing workflows.
  • Hologic: Hologic acquired HemoSonics and its Quantra QPlus viscoelastic testing system in 2021, making it a broad-incumbent competitor with a more recently developed viscoelastic platform aimed at surgical and perioperative settings.
  • Abbott: Abbott operates a broad diagnostics portfolio including point-of-care coagulation cartridges (i-STAT) widely used in hospitals worldwide. Represents a broad-incumbent competitor whose coagulation offering overlaps with VCM's clinical use cases.
  • IDEXX Laboratories: IDEXX is the dominant veterinary diagnostics company, with in-clinic chemistry, hematology, and coagulation offerings sold to the same veterinary practices Entegrion targets with VCMVet. Represents a broad-incumbent competitor in the veterinary channel.
  • Roche Diagnostics: Roche Diagnostics supplies coagulation testing solutions as part of its broad in-vitro diagnostics franchise and is the dominant central laboratory hemostasis partner for many US and EU hospitals.

Others

  • Zoetis: Zoetis is a global animal health company with diagnostics and reference laboratory offerings serving veterinary practices. Comparable to Entegrion's veterinary focus but positioned as an adjacent ecosystem participant rather than a direct viscoelastic competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Entegrion social profiles

Digital presence

Entegrion compliance and trust

Trust signal

Compliance1 record

Entegrion financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Entegrion leadership team

Management profile

Number of profiles

Profiles7 records

Entegrion funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Entegrion M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Entegrion

What does Entegrion do?

Entegrion develops and manufactures the VCM (Viscoelastic Coagulation Monitor), a point-of-care system that provides rapid, real-time hemostasis assessment using a small amount of fresh whole blood without chemical accelerants or sample manipulation. The platform is commercialized in two variants: VCMVet for veterinary practices and VCM Cascade for human clinical use in Europe and CE Mark-accepting regions.

Is Entegrion a public or private company?

Entegrion is a private company. It is classified as unknown and is currently operating.

When was Entegrion founded?

Entegrion was founded in 2002. It employs 11 to 50 people.

Where is Entegrion based?

Entegrion is headquartered in Durham, United States, in the North America region.

How does Entegrion make money?

One revenue line is on record: VCM Hardware and Consumables Sales.

Who are Entegrion's main competitors?

Direct peers on record are Werfen, Diagnostica Stago and Haemonetics Corporation. ELITech Group is listed as an emerging player. Broad incumbents are Siemens Healthineers, Hologic, Abbott, IDEXX Laboratories and Roche Diagnostics. Zoetis is listed as an others.

Does Entegrion have an API?

No public API is recorded for Entegrion.

What industry is Entegrion in?

Entegrion's product category is Point-of-Care Coagulation Diagnostics. Its primary akta.pro industry code is HLAHAOAC, Cardiac & Coagulation POCT (Troponin, BNP, INR/aPTT, D-dimer), with a secondary code of HLAFAMAC, Hematology & Coagulation Laboratories. Its NAICS code is 621511 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals